Deok Joon Shin
Director @ Korea Investment Partners
Deok Joon Shin is a venture - series unknown investor at Korea Investment Partners focused on Medical and Health Care. Deok-jun is a Director and specializes in mobile device and semiconductor components. He joined KIP in 2006 and serves as the lead manager of Fund 19(2011 KIF-Korea Investment Partners IT Venture Fund, KRW 25bn), and his recent investments include Haesung Optics and PLK Technology. Previously, Deok-jun was an investment professional at HanwhaInvestment, Hallim Venture Capital and KTB Network. Prior to that, he worked at Samsung Electronics as a researcher.Deok-jun received his B.S. and M.S. in Electrical Engineering, as well as his MBA from Sogang University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Deok Joon Shin invests in
Stages Deok Joon Shin invests in
Countries Deok Joon Shin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| I.M.LAB are dedicated to developing quality products based on such value in the healthcare industry. They hope their product will help save lives and help people. They promise to constantly contribute to making their world better. | $1.3M / Venture - Series Unknown / Aug 08, 2018 |
Co-Investors
Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.
Korea Investment Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Deok Joon Shin
Director
|
|||
Dong Yeob Kim
Executive Director & Chief Investment Officer
|
|||
Kun Ho Kim
Principal
|
|||
Min Q Kim
Director
|
|||
Richard Cui
Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Deok Joon Shin invest in?
Deok Joon Shin invests primarily in Medical and Health Care startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Deok Joon Shin?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Deok Joon Shin last invest?
The most recent investment recorded for Deok Joon Shin closed in Aug 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
